Ho-hsin Chang

Ms. Ho-hsin Chang

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 October 2025 in Computers in Biology and Medicine
Verified
Journal Article
Open access
HCHo-hsin Chang
Ho-hsin Chang
JHJoseph Harms
Joseph Harms
RCRex A. Cardan
Rex A. Cardan
JFJohn B. Fiveash
John B. Fiveash
RPRichard A. Popple
Richard A. Popple
CCCarlos E. Cardenas
Carlos E. Cardenas
Radiotherapy (RT) dose optimization is often labor-intensive, requiring repeated manual adjustments to achieve clinically acceptable plans. In this work, we introduce nnDoseNet, a deep learning framework designed to automate and streamline RT dose prediction. Building on the nnU-Net segmentation engine, nnDoseNet adapts this architecture for dose regression by incorporating specialized loss functions (including dose-volume histogram terms) and multi-channel input (CT, targets, organs-at-risk, and body mask). It also supports clinically relevant evaluation metrics (e.g., Dmean and D95). We evaluated nnDoseNet on the OpenKBP challenge dataset comprising 340 head-and-neck cancer cases (240 for training and 100 for testing). Multiple hyperparameters (U-Net depth, patch size, batch size, and loss function) were tested. The best-scored configuration achieved a dose score of 2.526 and a DVH score of 1.55 on the test set which are competitive with top submissions in the original challenge. Additional validation on an institutional cohort of 80 prostate cancer patients (45 training, 35 testing) demonstrated good agreement with clinical dose distributions (mean-squared error 0.817). By offering automated data preprocessing, systematic model training, and robust dose evaluation all within a single framework nnDoseNet reduces the complexity of building and testing dose prediction models. It accommodates diverse prescription doses, organ-at-risk definitions, and hardware configurations, making it a suitable benchmark for multi-institutional research. With its balance of simplicity, flexibility, and performance, nnDoseNet aims to accelerate the development, comparison, and clinical integration of advanced AI-driven dose prediction methods in radiotherapy. Importantly, the nnDoseNet output is a dose prediction, not a clinically deliverable treatment plan. Plan optimization, QA, and clinical approval remain separate steps outside the scope of this work.

21 March 2025 in Diagnostics
Verified
Journal Article
Open access
PDF file
YKYogesh Kumar
Yogesh Kumar
RCRex A. Cardan
Rex A. Cardan
HCHo-hsin Chang
Ho-hsin Chang
KHKatherine Anne Heinzman
Katherine Anne Heinzman
KGKadir Gultekin
Kadir Gultekin
CCCarlos E. Cardenas
Carlos E. Cardenas
Background/Objectives: Medical research institutions are increasingly leveraging artificial intelligence (AI) to enhance the processing and analysis of medical imaging data. However, scaling AI-driven medical image analysis often requires specialized expertise and infrastructure that individual labs may lack. A centralized solution is to establish a core facility—a shared institutional resource—dedicated to Automated Medical Image Processing and Analysis (AMIPA). Methods: This technical note offers a practical roadmap for institutions to create an AI-based core facility for AMIPA, drawing on our experience in building such a resource. Results: We outline the key components for replicating a successful AMIPA core facility, including high-performance computing resources, robust AI software pipelines, data management strategies, and dedicated support personnel. Emphasis is placed on workflow automation and reproducibility, ensuring researchers can efficiently and consistently process large imaging datasets. Conclusions: By following this roadmap, institutions can accelerate AI adoption in imaging workflows and foster a shared resource that enhances the quality and productivity of medical imaging research.

17 December 2025 in Neuro-Oncology Practice
Verified
Journal Article
Open access
YKYogesh Kumar
Yogesh Kumar
KLKayla Lewis
Kayla Lewis
HCHo-hsin Chang
Ho-hsin Chang
URUdbhav Ram
Udbhav Ram
GRGaurav N Rathi
Gaurav N Rathi
CCCarlos E. Cardenas
Carlos E. Cardenas
Background: Brain metastases (BMs) patients often receive multiple courses of radiotherapy (RT). Comparing follow-up imaging with RT plans is time-intensive and currently not possible in picture archiving and communication system (PACS). In this study, we aim to develop an automated tool to overlay pre-RT tumor contours onto follow-up MRI in the PACS to support response assessment and identification of untreated metastases, reducing review complexity and time. Methods: We built an AI-driven workflow that registers planning CT to follow-up MRI and propagates treated-lesion contours; outputs are exported as PACS-compliant DICOM. Performance was evaluated in 40 patients: 20 underwent quantitative comparison between manual and automated registrations using Dice similarity coefficient (DSC) and mean surface distance (MSD), following AAPM TG-132 guidelines; 20 additional patients (5-35 lesions per patient) underwent clinical evaluation of follow-up and pre-RT lesions contours visualization in PACS. Three physicians assessed these cases to measure review time and inter-observer agreement in treatment response classification (improved/stable vs indeterminate). Results: The workflow successfully registered all CT-MRI pairs. Mean DSC/MSD was: brain 0.97 ± 0.01/0.0 ± 0.0 mm, brainstem 0.89 ± 0.03/0.1 ± 0.1 mm, and gross tumor volumes 0.65 ± 0.18/0.6 ± 0.4 mm. Average physician review time per case decreased from 7.97 to 3.95 min with the automated workflow, and full inter-physician agreement increased from 72.4% to 93.5%. Conclusion: We developed and validated an AI-based tool that accurately fuses pre-RT contours with follow-up MRI for BMs, addressing a key gap in current PACS systems. The workflow significantly reduced review time per lesion and enhanced inter-physician agreement, and has the potential to enable faster, more consistent multidisciplinary follow-up assessment.

22 April 2026 in medRxiv
Verified
Preprint
Open access
PDF file
HCHo-hsin Chang
Ho-hsin Chang
RCRex Alexander Cardan
Rex Alexander Cardan
RNRitish Nedunoori
Ritish Nedunoori
JFJohn B. Fiveash
John B. Fiveash
RPRichard A. Popple
Richard A. Popple
CCCarlos E. Cardenas
Carlos E. Cardenas
Optimizing radiotherapy dose distributions remain a resource-intensive bottleneck. Existing AI-based dose prediction methods often have limited generalizability because they rely on small, heterogeneous datasets. We present nnDoseNetv2, an auto-configured, end-to-end framework for dose prediction across diverse disease sites (head and neck, prostate, breast, and lung), prescription levels (1.5–84 Gy), and treatment modalities (IMRT, VMAT, and 3D-CRT). By integrating machine-specific beam geometry with 3D structural information, the framework is designed to generalize across varied clinical scenarios. A single multi-site model was trained on 1,000 clinical plans. On sites seen during training, performance was comparable to specialized site-specific models. On unseen sites (liver and whole brain), the model outperformed site-specific models, with mean absolute errors of 2.46% and 6.97% of prescription, respectively. These results suggest that geometric awareness can bridge disparate anatomical domains while eliminating the need for site-specific model maintenance, providing a scalable and high-fidelity approach for personalized radiotherapy planning.

24 March 2025 in medRxiv
Verified
Preprint
Open access
PDF file
HCHo-hsin Chang
Ho-hsin Chang
JHJoseph Harms
Joseph Harms
RCRex Alexander Cardan
Rex Alexander Cardan
JFJohn B. Fiveash
John B. Fiveash
RPRichard A. Popple
Richard A. Popple
CCCarlos E. Cardenas
Carlos E. Cardenas
Background: Radiotherapy (RT) dose optimization is often labor-intensive, requiring repeated manual adjustments to achieve clinically acceptable plans. Purpose: In this work, we introduce nnDoseNet, a deep learning framework designed to automate and streamline RT dose prediction. Methods: Building on the nnU-Net segmentation engine, nnDoseNet adapts this architecture for dose regression by incorporating specialized loss functions (including dose–volume histogram terms) and multi-channel input (CT, targets, organs-at-risk, and body mask). It also supports clinically relevant evaluation metrics (e.g., gamma analysis and D95). Results: We evaluated nnDoseNet on the OpenKBP challenge dataset comprising 340 head-and- neck cancer cases (240 for training and 100 for testing). Multiple hyperparameters (U-Net depth, patch size, batch size, and loss function) were tested. The best-performing configuration achieved a dose score of 2.579 and a DVH score of 1.540 on the test set—competitive with top submissions in the original challenge. Additional validation on an institutional cohort of 80 prostate cancer patients (45 training, 35 testing) demonstrated good agreement with clinical dose distributions (mean-squared error 0.817) and improved target coverage compared to clinical plans. Conclusion: By offering automated data preprocessing, systematic model training, and robust dose evaluation—all within a single framework—nnDoseNet reduces the complexity of building and testing dose prediction models. It accommodates diverse prescription doses, organ-at-risk definitions, and hardware configurations, making it a suitable benchmark for multi-institutional research. With its balance of simplicity, flexibility, and performance, nnDoseNet aims to accelerate the development, comparison, and clinical integration of advanced AI-driven dose prediction methods in radiotherapy.